SEEKYO Competitors and Similar CompaniesClear all
SEEKYO's competitors and similar companies include IO Biotech, Cullgen, AgomAb Therapeutics and Arcellx.
 IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. |  Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. |  AgomAb Therapeutics AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues. | |||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 2018 | Founding Date 2017 | Founding Date 2015 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Poitiers, FR HQ Chasseneuil Du Poitou, FR | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Antwerpen, BE HQ Gent, BE | Locations Gaithersburg, US HQ |
Employees | Employees 833% increase | Employees 19 | Employees 4 | Employees 62 | Employees 78 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 85.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.7 b |
Financial | |||||
Net income | Net income N/A | Net income ($95.5m) (FY, 2024) | Net income N/A | Net income N/A | Net income ($228.9m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 720.5k (over 6 years ago) | Latest funding round N/A | Latest funding round $ 16m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 720.5k | Total funding raised $ 165.9m | Total funding raised $ 31m | Total funding raised $ 97.6m | Total funding raised $ 200m |
For sources of this data, please see the company profile
View Company Profiles
IO Biotech
HQ
New York, US
Employees
19
IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
View companyCullgen
HQ
San Diego, US
Employees
4
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View companyAgomAb Therapeutics
HQ
Antwerpen, BE
Employees
62
AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues.
View company
Arcellx
HQ
Gaithersburg, US
Employees
78
Arcellx is a clinical-stage biotechnology company developing adaptive immune cell therapies.
View company